Safety and clinical activity of combined romidepsin and azacitidine therapy in high risk acute myeloid leukemia: preliminary results of the Romaza Trial
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.